Navigation Links
APS Healthcare and Thomson Reuters to Manage New York State's Medicaid Clinical Best Practices Review Program
Date:4/16/2009

APS Healthcare to serve the State of New York, using Advantage Suite's advanced methodologies and business intelligence applications to power APS' innovative and data-driven interventions," said Jon Newpol, executive vice president of the Thomson Reuters Healthcare and Science business. "We are confident our services will benefit the state, its healthcare practitioners and ultimately, its Medicaid members."

The project, scheduled to start by early Summer 2009, will review the healthcare services delivered to three million New York fee-for-service Medicaid recipients.

About APS Healthcare

APS Healthcare, headquartered in White Plains, NY, is a leading provider of specialty healthcare solutions. The company partners with state agencies in 24 states and Puerto Rico, which serve more than 40 percent of the nation's Medicaid population. APS delivers customized, integrated healthcare solutions that help people engage in behaviors that optimize their health status. By uniting all participants in the healthcare landscape -- individuals, practitioners and payers -- APS improves overall health and reduces total healthcare expenditures. For more information, visit www.apshealthcare.com.

About Thomson Reuters

Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial, legal, tax and accounting, scientific, healthcare and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs more than 50,000 people in 93 count
'/>"/>

SOURCE APS Healthcare, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
3. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
4. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
5. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
6. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
7. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
10. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
11. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company ... to manufacture proteins including biosimilar therapeutics, today provided ... the second quarter ended June 30, 2014. ... public offering, we have the capital to continue ... our proprietary protein expression platform," stated Bertrand C. ...
(Date:8/29/2014)... are based on electrons, but one of the most ... i.e. circuits based on light (photons) instead of electrons. ... a stream of single photons and control their direction. ... attempts to achieve this control, but now scientists at ... steady stream of photons emitted one at a time ...
(Date:8/29/2014)... New York (PRWEB) August 29, 2014 ... valued at $5.6 billion in 2019. It is ... from 2013 to 2019, and was valued at ... report published by Transparency Market Research. , For ... visit: http://www.transparencymarketresearch.com/companion-diagnostics-market.html . , The research report, ...
(Date:8/29/2014)... According to a new market report published by ... was valued at USD 3,754.6 million in 2012 and is ... a CAGR of 5.9% from 2013 to 2019. , Nearly ... afflicted by bone and joint disorders, and this number is ... and will continue to increase the demand for orthobiologics. Other ...
Breaking Biology Technology:Pfenex Reports Second Quarter 2014 Results and Provides Business Update 2Pfenex Reports Second Quarter 2014 Results and Provides Business Update 3Pfenex Reports Second Quarter 2014 Results and Provides Business Update 4Pfenex Reports Second Quarter 2014 Results and Provides Business Update 5Pfenex Reports Second Quarter 2014 Results and Provides Business Update 6Pfenex Reports Second Quarter 2014 Results and Provides Business Update 7Pfenex Reports Second Quarter 2014 Results and Provides Business Update 8Breakthrough in light sources for new quantum technology 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3
... GlaxoSmithKline Will Also Be Vying to Capture, Shares of ... ... from Decision Resources, WALTHAM, Mass., Nov. 19 Decision ... pharmaceutical and,healthcare issues, finds that the most promising antibiotics in ...
... 18 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis,(ASX: PXS, Nasdaq: PXSL) today ... Purchase Plan which closed on 9 November 2007. ... purchase up to $5,000 worth of,shares each at ... the,recent placement. A total of 2,496 shareholders ...
... BERKELEY HEIGHTS, N.J., Nov. 16 Genta,Incorporated (Nasdaq: ... letter from the NASDAQ Stock Market stating that the,Company,s ... Global,Market because the Company does not comply with the ... as set forth in,Marketplace Rule 4450(a)(3). The Company intends ...
Cached Biology Technology:Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline 2Pharmaxis Closes Share Purchase Plan 2Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market 2Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market 3
(Date:8/29/2014)... number of connections in transcription factor networks (TFNs) to ... study published in PLOS Computational Biology in ... contributes to a network,s resilience against mutations. , ... of TFN models has a greater effect on robustness ... assortativity," said Dov A. Pechenick, PhD, lead author and ...
(Date:8/29/2014)... of marine phytoplankton, such as the prolific bloomer ... (thiamine), researchers have discovered. The finding contradicts the common ... eukaryotic microbes depend on scarce supplies of thiamine in ... way to think about the ocean," says CIFAR Senior ... ISME Journal paper with CIFAR fellows John ...
(Date:8/29/2014)... Tibetan plateau -- the largest topographic anomaly above sea ... profound effect on climate and its reflection of continental ... , Katharine Huntington and colleagues employ a cutting-edge geochemical ... fossil snail shells to investigate the uplift history of ... range widely on the timing of surface uplift of ...
Breaking Biology News(10 mins):Assortativity signatures of transcription factor networks contribute to robustness 2Not all phytoplankton in the ocean need to take their vitamins 2Not all phytoplankton in the ocean need to take their vitamins 3Snails tell of the rise and fall of the Tibetan Plateau 2Snails tell of the rise and fall of the Tibetan Plateau 3Snails tell of the rise and fall of the Tibetan Plateau 4Snails tell of the rise and fall of the Tibetan Plateau 5Snails tell of the rise and fall of the Tibetan Plateau 6Snails tell of the rise and fall of the Tibetan Plateau 7
... eye, and intestinal tract infections, and, like other viruses, ... order to produce proteins and their own viral spawn. ... from Chinese and Australian universities has found a way ... damage the viruses in the laboratory environment, before they ...
... -- Parkinson,s disease is marked by the abnormal accumulation ... in the substantia nigra region of the brain. A ... NACP-Rep1 has been implicated as a risk factor for ... variants of NACP-Rep1 and its interaction with the microtubule-associated ...
... having an effect on Earth,s ecosystems but it,s not just ... we are causing. Now you can add an over-abundance of ... question is how large of an impact will be felt. ... Science (Dec. 16, 2011), Arizona State University researcher ...
Cached Biology News:Plasma treatment zaps viruses before they can attack cells 2Genetic factors can predict the progression of Parkinson's disease 2Researchers assess effects of a world awash in nitrogen 2
Lyophilized. Purity: ≥90% by electrophoresis. Reconstitute in 0.3% NaCl. Prepared from serum that has been shown by certified tests to be negative for HBsAg and for HIV and HCV antibodies. ...
p230 trans Golgi Purified Anti-Human clone 15, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details....
... and highly photostable FluoSpheres microspheres have ... variety of applications requiring probes that ... protein- and other macromolecule-labeled microspheres have ... to bind to non-target surfaces in ...
DNA Polymerase I Large (Klenow) Fragment is a DNA polymerase that lacks the 5'Cut Site3' exodeoxyribonuclease activity of intact DNA Polymerase I but it contains the 3'Cut Site5' exodeoxyribonuclease...
Biology Products: